Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
6 Trail blazing Bicycles for Rough terrain Undertakings - 2Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
- 3Vote In favor of Your Favored Web-based Visual depiction Administration
- 4Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets
- 5How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- Germany's Bundestag extends two armed forces missions abroad
- Productive CRM Programming for Client Relationship The executives
- Audits of 6 Specialty Mixed drinks
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- The Manual for Electric Vehicles that will be hot merchants in 2023
- The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- Two die and thousands homeless after flooding hits Russia's Dagestan
- Key takeaways from Sen. Bill Cassidy's interview on 'Face the Nation' with Margaret Brennan
- Figure out How to Acquire Rewarding Open Record Rewards
